UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment Journal article
Weiss J.M., Back T.C., Scarzello A.J., Subleski J.J., Hall V.L., Stauffer J.K., Chen X., Micic D., Alderson K., Murphy W.J., Wiltrout R.H.. Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment[J]. Proceedings of the National Academy of Sciences of the United States of America, 2009, 106(46), 19455-19460.
Authors:  Weiss J.M.;  Back T.C.;  Scarzello A.J.;  Subleski J.J.;  Hall V.L.; et al.
Favorite | TC[WOS]:53 TC[Scopus]:57 | Submit date:2018/11/06
Cd40  Chemokines  Tumor Immunotherapy  
Development of regulatory T cells requires IL-7R{alpha} stimulation by IL-7 or TSLP Journal article
Mazzucchelli R., Hixon J.A., Spolski R., Chen X., Li W.Q., Hall V.L., Willette-Brown J., Hurwitz A.A., Leonard W.J., Durum S.K.. Development of regulatory T cells requires IL-7R{alpha} stimulation by IL-7 or TSLP[J]. Blood, 2008, 112(8), 3283-3292.
Authors:  Mazzucchelli R.;  Hixon J.A.;  Spolski R.;  Chen X.;  Li W.Q.; et al.
Favorite | TC[WOS]:101 TC[Scopus]:106 | Submit date:2018/11/06